1-20 of 36
T. Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3815: Investigating the role of bone marrow microenvironment dysregulation at remission in disease outlook of multiple myeloma

Julia T. Wang, Mark Fiala, Julie Fortier, Ruiyang Liu, Reyka Jayasinghe, Ravi Vij, Li Ding
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3815.
DOI: https://doi.org/10.1158/1538-7445.AM2022-3815
Published: 15 June 2022
View article
Journal Articles

Abstract 1068: Anti-DR5 agonist IgM antibody IGM-8444 combined with SMAC mimetic birinapant induces strong synergistic tumor cytotoxicity

Beatrice T. Wang, Melanie Desbois, Susan E. Calhoun, Thomas J. Matthew, Poonam Yakkundi, Ling Wang, Xingjie Chen, Tasnim Kothambawala, Miho Oyasu, Maya F. Kotturi, Genevive Hernandez, Xiaohan Liu, Marvin S. Peterson, Eric W. Humke, Bruce A. Keyt, Angus M. Sinclair
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 1068.
DOI: https://doi.org/10.1158/1538-7445.AM2022-1068
Published: 15 June 2022
View article
Journal Articles

Abstract 52: Mechanistic evaluation of anti-DR5 IgM antibody IGM-8444 with potent tumor cytotoxicity, without in vitro hepatotoxicity

Beatrice T. Wang, Tasnim Kothambawala, Kevin C. Hart, Xingjie Chen, Melanie Desbois, Susan E. Calhoun, Poonam Yakkundi, Rodnie A. Rosete, Yuan Cao, Katie Cha, Thomas J. Matthew, Ling Wang, Paul R. Hinton, Maya K. Leabman, Genevive Hernandez, Maya F. Kotturi, Eric W. Humke, Angus M. Sinclair, Bruce A. Keyt
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 52.
DOI: https://doi.org/10.1158/1538-7445.AM2021-52
Published: 01 July 2021
View article
Journal Articles

Abstract PD3-07: A phase II pre-surgical trial of lapatinib for the treatment of women with HER2 positive or EGFR positive ductal carcinoma in situ

PS Thomas, A Contreras, S Pruthi, H Krontiras, M Rimawi, J Garber, T Wang, SG Hilsenbeck, LA Vornik, T Gilmer, R Friedman, BM Heckman-Stoddard, B Dunn, H Kuerer, PH Brown
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): PD3-07.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-PD3-07
Published: 15 February 2019
View article
Journal Articles

Abstract PD6-02: A randomized, controlled trial of high dose vs. standard dose vitamin D for aromatase inhibitor-induced arthralgia in breast cancer survivors

P Niravath, T Wang, SG Hilsenbeck, K Lipscomb, A Pavlick, S Jiralerspong, J Nangia, M Ellis, F Ademuyiwa, M Cherian, A Frith, C Ma, H Park, C Rigden, R Suresh, CK Osborne, MF Rimawi
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): PD6-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-PD6-02
Published: 15 February 2019
View article
Journal Articles

Abstract P4-15-05: Biomarkers of response to neoadjuvant endocrine therapy with anastrozole (Ana) alone or in combination with fulvestrant (Ful) in ER-positive (ER+) HER2-negative (HER2-) breast cancer (PACT01 trial)

S Dhamne, C Nagi, T Wang, AC Pavlick, B Reusser, R Schiff, N Julie, P Niravath, EJ Silberfein, EL Sedgwick, KA Sepulveda, C Gutierrez, SG Hilsenbeck, JC Chang, CK Osborne, MF Rimawi
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P4-15-05.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-P4-15-05
Published: 15 February 2019
View article
Journal Articles

Abstract P2-08-63: The relationship between serum level of copper and ceruloplasmin and pathologic and clinical characteristics in early breast cancer patients

J Fan, Y Wan, G Zhao, T Wang
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P2-08-63.
DOI: https://doi.org/10.1158/1538-7445.SABCS18-P2-08-63
Published: 15 February 2019
View article
Journal Articles

Abstract PD2-01: Ultrasound together with clinical indexes cannot predict sentinel lymph node metastasis for ultrasound-axillary lymph node-negative breast cancer patients

X Chen, Y He, L Huo, J Li, Y Xie, T Wang, Z Fan, T Ouyang
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): PD2-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-PD2-01
Published: 15 February 2018
View article
Journal Articles

Abstract P2-09-12: Independent validation of the HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer

A Prat, C De Angelis, T Pascual, C Gutierrez, T Wang, L Paré, B Rexer, J Cortes, A Forero, A Llombart, AC Wolff, I Krop, P Galván, AC Pavlick, P Villagrasa, SG Hilsenbeck, R Schiff, CK Osborne, MF Rimawi
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P2-09-12.
DOI: https://doi.org/10.1158/1538-7445.SABCS17-P2-09-12
Published: 15 February 2018
View article
Journal Articles

Abstract P2-04-27: CTLA-4 and PD-1 checkpoint inhibitors enhance individually tailored adaptive anti-tumor immune responses to overcome tumor immunosuppression and effectively treat triple-negative breast cancer

ZC Hartman, EJ Crosby, J-P Wei, X-Y Yang, G-J Lei, T Wang, C-X Liu, P Agarwal, MS Morse, HK Lyerly
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P2-04-27.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-P2-04-27
Published: 15 February 2017
View article
Journal Articles

Abstract S5-02: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer

JR Nangia, T Wang, PA Niravath, K Otte, CR Osborne, S Papish, FA Holmes, J Abraham, S Goldfarb, JG Courtright, RJ Paxman, MB Rude, SG Hilsenbeck, CK Osborne, MF Rimawi
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): S5-02.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-S5-02
Published: 15 February 2017
View article
Journal Articles

Abstract PD2-04: FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer

X Fu, R Pereira, D Zhao, SY Jung, R Jeselsohn, CJ Creighton, M Shea, A Nardone, CD Angelis, A Tsimelzon, T Wang, C Gutierrez, S Huang, DP Edwards, MF Rimawi, SG Hilsenbeck, M Brown, K Chen, CK Osborne, R Schiff
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): PD2-04.
DOI: https://doi.org/10.1158/1538-7445.SABCS16-PD2-04
Published: 15 February 2017
View article
Journal Articles

Abstract 3721: A camptothecin-containing nanoparticle-drug conjugate combination with DDR agents provides a novel approach to increasing therapeutic index

Lenka Oplustil O’Connor, Anderson T. Wang, David R. Jones, Rajesh Odedra, Michael Spreadborough, Joanne Wilson, Aaron Smith, Peter Cotton, Jaimini Reens, Jen Barnes, Victoria Sheridan, Scott Eliasof, Andres Tellez, Alan Lau, Claire Sadler, Mark J. O’Connor
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3721.
DOI: https://doi.org/10.1158/1538-7445.AM2016-3721
Published: 15 July 2016
View article
Journal Articles

Abstract OT3-02-08: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer

JR Nangia, T Wang, M Rude, C Osborne, S Papish, J Abraham, F Holmes, M Savin, R Paxman, SG Hilsenbeck, CK Osborne, M Rimawi
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): OT3-02-08.
DOI: https://doi.org/10.1158/1538-7445.SABCS15-OT3-02-08
Published: 15 February 2016
View article
Journal Articles

Abstract 2213: Evaluation of bias associated with high-multiplex, target-specific pre-amplification

Steven T. Okino, Michelle Kong, Yan T. Wang
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2213.
DOI: https://doi.org/10.1158/1538-7445.AM2015-2213
Published: 01 August 2015
View article
Journal Articles

Abstract LB-277: Irregular menstruation predicts increased risk of subsequent ovarian cancer death in a prospective cohort, The Child Health and Development Studies

Barbara A. Cohn, Piera M. Cirillo, Erica T. Wang, Marcelle I. Cedars
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-277.
DOI: https://doi.org/10.1158/1538-7445.AM2014-LB-277
Published: 01 October 2014
View article
Journal Articles

Abstract OT1-1-04: HER2 status of circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable biomarker in anti-HER2 therapy

Z Jiang, L Li, Y Liu, T Wang, S Zhang, Y Yuan, L Bian, Q Liu, F Qi
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): OT1-1-04.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-OT1-1-04
Published: 15 December 2013
View article
Journal Articles

Abstract PD1-2: PIK3CA mutations and/or low PTEN predict resistance to combined anti-HER2 therapy with lapatinib and trastuzumab and without chemotherapy in TBCRC006, a neoadjuvant trial of HER2-positive breast cancer patients

A Contreras, S Herrera, T Wang, I Mayer, A Forero, R Nanda, M Goetz, JC Chang, AC Pavlick, SAW Fuqua, C Gutierrez, SG Hilsenbeck, MM Li, CK Osborne, R Schiff, MF Rimawi
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): PD1-2.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-PD1-2
Published: 15 December 2013
View article
Journal Articles

Abstract P6-10-05: First-line chemotherapy versus first-line endocrine therapy in hormone receptor positive HER2 negative patients with metastatic breast cancer in China: Results of the study of breast cancer group of the Chinese Society of Clinical Oncology (CSCO)

T Wang, TT Yang, LJ Yang, HY Song, CQ Ouyang, JX Wang, CX Hu, JG Zhang, HB Xu, FJ Feng, SZ Tong, FZ Jiang
Journal: Cancer Research
Cancer Res (2013) 73 (24_Supplement): P6-10-05.
DOI: https://doi.org/10.1158/0008-5472.SABCS13-P6-10-05
Published: 15 December 2013
View article
Journal Articles

Abstract P4-08-07: Novel insight into the tumor “flare” phenomenon and lapatinib resistance

JA Piede, S Zhao, L Liu, HK Lyerly, T Osada, T Wang, W Xia, N Spector
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P4-08-07.
DOI: https://doi.org/10.1158/0008-5472.SABCS12-P4-08-07
Published: 15 December 2012
View article